SMF_Hmgxb3 inhibitors constitute a specialized class of chemical compounds designed to selectively modulate the activity of the SMF (Structural Maintenance of Chromosomes) domain-containing protein HMGXB3. The HMGXB3 protein is characterized by the presence of a high mobility group box (HMG-box) domain, indicative of its involvement in DNA binding and chromosomal maintenance. The inhibitors developed for SMF_Hmgxb3 exhibit a specific chemical structure, allowing them to interact selectively with defined binding sites on the HMGXB3 protein, thereby influencing its molecular activities within the cellular context. The meticulous design of these inhibitors is essential for ensuring a high degree of specificity, minimizing unintended effects on other cellular components or proteins within the broader SMF domain-containing family.
The mechanism of action of SMF_Hmgxb3 inhibitors involves disrupting the normal functioning of the HMGXB3 protein, potentially impacting processes associated with chromosomal maintenance and DNA organization. As a member of the SMF domain-containing family, HMGXB3 may play a role in regulating the structural integrity of chromosomes during various cellular processes, including cell division and DNA repair. The selectivity of these inhibitors is crucial to prevent interference with other closely related SMF domain-containing proteins or chromosomal maintenance pathways. As researchers delve into the intricacies of genomic stability and chromosomal dynamics, SMF_Hmgxb3 inhibitors serve as valuable tools, allowing for the investigation of the precise molecular mechanisms governed by HMGXB3. The study of this chemical class contributes to a deeper understanding of the role played by SMF_Hmgxb3 in cellular physiology, offering insights into its potential functions within the complex networks that regulate chromosomal architecture and genomic stability. Overall, the exploration of SMF_Hmgxb3 inhibitors provides a platform for advancing our understanding of the molecular landscape surrounding SMF domain-containing proteins and their roles in maintaining genomic integrity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Sirolimus forms a complex with FKBP12 and inhibits mTOR, a kinase important for protein synthesis, which might reduce the expression of proteins like HMGXB3. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits eukaryotic protein synthesis by interfering with the translocation step on ribosomes, potentially decreasing HMGXB3 protein levels. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB inhibits RNA synthesis by blocking the activation of RNA polymerase II, which could consequently reduce HMGXB3 expression. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide inhibits DNA topoisomerase II, leading to DNA damage and possibly affecting transcription and expression of genes like HMGXB3. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Rocaglamide has been reported to inhibit translation initiation and may reduce the synthesis of various proteins, including potentially HMGXB3. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA and inhibits RNA polymerase movement, thereby decreasing RNA synthesis and possibly affecting HMGXB3 expression. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide has been shown to inhibit the transcription of various genes by affecting transcription factors and could potentially decrease HMGXB3 expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine intercalates into DNA and RNA, which can disrupt replication and transcription processes, potentially affecting HMGXB3 expression. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Aphidicolin is an inhibitor of DNA polymerase alpha and delta, leading to S-phase arrest in the cell cycle, which may reduce the expression of HMGXB3. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Amanitin is an inhibitor of RNA polymerase II and III, preventing mRNA synthesis and potentially decreasing the expression of HMGXB3. | ||||||